Proactive TDM Versus Standard Use of Biologics in Psoriasis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Proactive TDM Versus Standard Use of Biologics in Psoriasis — Stella

Recruiting

Back to Psoriasis Vulgaris trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(15 sites)

Belgium

AZ Sint-Jan, Bruges

CHU Saint-Pierre, Brussels

UCL Saint-Luc, Brussels

ULB Erasme, Brussels

UZ Brussel, Brussels

Key details

Phase

Post-approval study

Sponsor

University Hospital, Ghent

Collaborators

Belgium Health Care Knowledge Centre

Enrollment target

~210 participants

Started

December 2024

Primary completion

March 2028

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov